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Case Report
CHEDIAK-HIGASHI SYNDROME
Emad uddin Siddiqui1, Shaheena Hanif2
ABSTRACT
Chediak Higashi Syndrome is a rare inherited autosomal recessive disorder of immune system.
Susceptibility to infection due to phagocyte dysfunction ranges from recurrent skin infection to
over whelming fatal systemic infection. A five years old male child was admitted on 31st March
2006 with the complaints of pallor, fever & ear discharge for 6 month. He was treated by several
medications but had temporary relief. The ear discharge was bilateral, foul smelling and of
yellowish color. Past history was significant with episodes of abscess involving the different parts
of body. Myeloid precursors shows giant, purple stained granules mainly in metamyelocytes, band
cells and mature neutrophils.
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INTRODUCTION
This was in 1943 when Beguez briefly out
line the disease followed by Stein Brinck (1948)
and then by Chediak (1952) & Higashi (1954).
This is a rare inherited autosomal recessive
disorder of immune system characterized by
increase susceptibility to infections due to
defective granulation of neutrophil and abnor-
mal function of natural killer cell with bleed-
ing diathesis, partial occulocutanous albinism,
progressive peripheral neuropathy and the ten-
dency to develop a life threatening lymphoma
like syndrome.1 Susceptibility to infection from
phagocytic dysfunction ranges from mild
recurrent skin infections to overwhelming
fatal systemic infection. Affected patients are
more susceptible to bacterial and fungal infec-
tions, but have a normal resistance to viral
infections. Majority of patients are diagnosed
in infancy due to the severity of the infection
or the unusual presentation of the organism,
but some escape the diagnosis until adulthood.
CASE REPORT
This is a case of five years old male child who
was admitted on 31st March 2006 with the com-
plaints of pallor, fever & ear discharge for last
six months. He received multiple drugs with
several antibiotics but had temporary relief.
The ear discharge was bilateral, foul smelling
& yellowish green in colored.
Past history was significant; he had multiple
abscesses involving the different parts of body
at different occasions. The last abscess
appeared some two months back affecting the
injection site and took one month to resolve
even with antibiotics. There were multiple old
healed infected areas on face and limb. He had
been treated for repeated episodes of diarrhoea
and pneumonia in past with oral and inject-
able antibiotics. He had also been transfused
several times in the last few months because of
pancytopenia. He was vaccinated according
to EPI schedule. There was no significant
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family history. His birth was uneventful. His
height and weight was below 5th centile. He
was febrile (101 F) pulse of 120/min and R/R
of 32/min. The child was anemic with de-pig-
mented skin rash and hairs, while cervical
lymph nodes were enlarged. Liver was three
cm palpable below the right costal margin, on
tender, smooth surface and sharp border,
spleen was also palpable 3 cm along its long
axis. Other system was intact. His gait was
normal.
His initial CBC shows Hb of 6gm/dl, TLC of
1500 (neutrophils of 481/cumm, lymphocytes
of 950/cumm) Platelets 2000/cumm. Serum
Complement {C3-1.51(0.9-1.8), C4–0.26(0.1-
0.4)} and immunoglobulin levels were {IgG–
9.74 (7-16), IgA–0.29 (0.7-4.0), IgM–0.88 (0.4-
2.3)}. Bone marrow D/R shows all three cell
lines with M:E ratio of 15:1. Erythopoiesis
shows dyserythopoietic changes including
nuclear cytoplasmic disproportion. Myeloid
precursors shows giant, purple stained gran-
ules mainly in metamyelocytes, band cells and
mature neutrophils. These findings are sugges-
tive of Chediak Higashi syndrome.
He was treated with antibiotics, high dose
Ascorbic acid and transfused with packed cell
and platelets. Patient was discharged safely.
He continued the follow-up for six months
before he was lost the follow up.
DISCUSSION
The gene of CHS (Chediak-Higashi
Syndrome) is located on chromosome 1, q42-
44. This gene effects protein synthesis or/and
maintains of storage & secretory granules
lysosomal of leukocytes and fibroblast, dense
bodies of platelets, azurophils granules of neu-
trophils and melanosomes of melanocytes all
are involved.2 The defective gene, called LYST,
has been identified.3 Deficiency of proteolytic
enzymes, impaired function of polymorph
nuclear cells due to abnormal micro tubular
assembly and impaired chemotaxis all leads to
impaired immunity.
Phagocytic disorders may be divided into
extrinsic and intrinsic defects: Extrinsic defects
include opsonic abnormalities secondary to
deficiencies of antibody and complement fac-
tors leading to neutropenia by suppression of
the production of granulocytes, or to a decrease
in the number of circulating neutrophils by the
presence of autoantibody directed against
neutrophil antigens.
Intrinsic disorders of granulocytes results
from defects in granulocyte killing ability and
those that inhibit chemotaxis (cell movement).
Intrinsic disorders of phagocytic killing ability
include chronic granulomatous disease, glyco-
gen storage disease type Ib, Chediak-Higashi
syndrome, and specific granule deficiency.4
Almost all cells of patients with CHS shows
some form of markedly abnormal “giant”
cytoplasmic granules which are formed by the
inappropriate fusion of lysosomes and
endosomes. Neutrophils are mildly depressed
and have impaired chemotaxis and intracellu-
lar killing, natural killer cell function are also
impaired. Similar finding were found in the
microscopic examination of bone marrow
aspirates of our patient. His peripheral smear
also reveals neutropenia. Same for melanocytes
with failure to properly disperse the giant
melanosomes, resulting in hair shaft devoid of
pigments. This leads to appearance of skin and
hair follicle that is lighter than expected as was
in our case.
These children are more prone to recurrent
skin infections. Other sites of involvement are
mucous membrane, lung and intestine.
Affected children are prone to have gram
positive and gram negative organism. The
neuropathy is usually sensory, motor may also
be involved associated with ataxia and it may
be the late presentation. Ataxia was not
present in our case, it might be due to early
presentation.
The most devastating symptoms are lym-
phoma like presentation characterized by pan-
cytopenia, high grade fever, lymphohistocytic
infiltration of liver, spleen and lymph nodes.
Death among patients with CHS is often due
to sequelae of infection. Patients who do not
succumb eventually enter the “accelerated
phase” of the disease characterized by mas-
sive lymphohistiocytic infiltration of virtually
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all organ systems, resulting in pancytopenia
and even more profound immune deficiency.
When there is suspicion the diagnosis of CHS
can be established by examination of a stained
peripheral blood smear demonstrating abnor-
mal giant granules in neutrophil, supported by
the suggestive history and clinical findings.5
High dose Ascorbic acid (200mg/kg) may im-
prove the clinical course in some patients.1 CHS
is treated by prophylaxis and aggressive
therapy of bacterial infections. Splenectomy
has been used with some success in the accel-
erated phase.6 We started the conventional
therapy in our patient who initially showed
some improvement but ultimately lost during
follow up.
Bone marrow transplantation (BMT) is the
only curative treatment from a HLA compat-
ible matched donor. The BMT reconstitutes
normal haematopoietic and immunologic
function and correct the natural killer cell
deficiency in patients. BMT does not improves
the neuropathy.1
BMT has been successful in a number of cases.
One series of 10 patients with CHS reported
that six out of seven patients who received a
HLA-identical marrow and one out of three
recipients of HLA-non identical marrow re-
mained healthy at a median follow-up of 6.5
years (range of 1.5 to 13 years).7
An HLA-identical sibling bone marrow
transplant was done for a patient with
Chediak-Higashi syndrome. The preparative
regimen included intravenous fludarabine
(40mg/m2/dx4) and busulfan (130 mg/m2/
dx4). Busulfan was given once daily. Pharma-
cokinetic studies showed the area under the
concentration-time curve of the once-daily in-
travenous busulfan was similar to that seen
with the total daily dose administered with an
every-6-hourly regimen. Toxicity was minimal.
Myeloid engraftment occurred on day +17 and
donor chimerism was complete. Fludarabine
and once-daily intravenous busulfan is well
tolerated and is adequate for engraftment of
sibling transplant in Chediak-Higashi
syndrome.8
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